The Associations between Racial Disparities, Health Insurance, and the Use of Amputation as Treatment for Malignant Primary Bone Neoplasms in the US: A Retrospective Analysis from 1998 to 2016.
Hans LapicaMatan OzeryHarsha RajuGrettel CastroPura Rodriguez de la VegaNoël Christopher BarengoPublished in: International journal of environmental research and public health (2022)
Primary bone neoplasms (PBNs) represent less than 1% of diagnosed cancers each year. Significant treatment disparities exist between racial and ethnic groups. We investigated patients with PBNs to determine an association between race/ethnicity and procedure-type selection. A non-concurrent cohort study was conducted using the SEER database. Patients diagnosed with PBNs between 1998 and 2016 were included ( n = 5091). Patients were classified into three racial groups (Black, White and Asian Pacific Islanders) and were assessed by procedure-type received. The outcome was amputation. Race was not associated with increased amputation incidence. Hispanic patients had a 40% increased likelihood of amputation (OR 1.4; 95% CI 1.2-1.6). Insurance status was an independent predictor of procedure selection. Uninsured patients were 70% more likely to receive amputation than insured patients (OR 1.7; 95% CI 1.1-2.8). We recommend provider awareness of patients less likely to seek regular healthcare in the context of PBNs.
Keyphrases
- end stage renal disease
- ejection fraction
- chronic kidney disease
- healthcare
- newly diagnosed
- peritoneal dialysis
- emergency department
- primary care
- radiation therapy
- minimally invasive
- social media
- body composition
- lower limb
- single molecule
- patient reported
- replacement therapy
- locally advanced
- rectal cancer
- adverse drug
- combination therapy